Drug Shortage Report for JAMP-GABAPENTIN TABLETS
| Report ID | 64222 |
| Drug Identification Number | 02402297 |
| Brand name | JAMP-GABAPENTIN TABLETS |
| Common or Proper name | Gabapentin |
| Company Name | JAMP PHARMA CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | GABAPENTIN |
| Strength(s) | 800MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | N03AX |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2018-10-12 |
| Estimated end date | |
| Actual end date | 2019-01-31 |
| Shortage status | Resolved |
| Updated date | 2019-03-01 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2019-03-01 | French | Compare |
| v7 | 2019-03-01 | English | Compare |
| v6 | 2018-12-19 | French | Compare |
| v5 | 2018-12-19 | English | Compare |
| v4 | 2018-10-15 | French | Compare |
| v3 | 2018-10-15 | English | Compare |
| v2 | 2018-10-15 | French | Compare |
| v1 | 2018-10-15 | English | Compare |
Showing 1 to 8 of 8